Home › Funds › BAKER BROS. ADVISORS LP › INSM
BAKER BROS. ADVISORS LP position in INSM
INSMED INC · Health Care
BAKER BROS. ADVISORS LP reported holding 8,796,111 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$937.8M, representing 4.90% of its reported portfolio and ranking #7 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed INSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BAKER BROS. ADVISORS LP's INSM position evolved
BAKER BROS. ADVISORS LP first disclosed a stake in INSM in Q3 2023 at 343,000 shares (US$8.7M). The position peaked in Q1 2026 at 7,421,111 shares, worth US$1.21B. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 8,796,111 shares valued at US$937.8M — an increase of 1,375,000 shares quarter over quarter.. Notable position changes include a 943% increase in Q2 2024 (shares rose 8% over the following quarter), a 43% increase in Q2 2025 (shares rose 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 343.00K | $8.66M | New |
| Q4 2023 | 343.00K | $10.63M | Hold |
| Q1 2024 | 343.00K | $9.31M | Hold |
| Q2 2024 | 3.58M | $239.59M | Add |
| Q3 2024 | 4.42M | $322.36M | Add |
| Q4 2024 | 5.01M | $345.67M | Add |
| Q1 2025 | 5.38M | $410.49M | Add |
| Q2 2025 | 7.71M | $776.23M | Add |
| Q3 2025 | 6.70M | $965.37M | Reduce |
| Q4 2025 | 6.59M | $1.15B | Reduce |
| Q1 2026 | 7.42M | $1.21B | Add |
| Q2 2026 | 8.80M | $937.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INSM and 13F data
INSM (INSMED INC) is a Health Care company. 39 other funds we track also report a position in INSM — the largest reported positions include Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M), D. E. Shaw & Co (US$633.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INSM
- Darwin Global Management, Ltd. 6.43M sh · $673.60M · Q2 2026
- Orbis Allan Gray Ltd 6.08M sh · $647.88M · Q2 2026
- D. E. Shaw & Co 5.94M sh · $633.12M · Q2 2026
- Artisan Partners Limited Partnership 5.44M sh · $580.20M · Q2 2026
- RTW INVESTMENTS, LP 4.84M sh · $516.35M · Q2 2026
- Maverick Capital 2.15M sh · $229.31M · Q2 2026
- MAVERICK CAPITAL LTD 2.15M sh · $229.31M · Q2 2026
- Qube Research & Technologies Ltd 1.68M sh · $179.37M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.63M sh · $173.74M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $170.59M · Q2 2026
- Bellevue Group AG 1.39M sh · $148.57M · Q2 2026
- Duquesne Family Office LLC 1.35M sh · $143.94M · Q2 2026
More on BAKER BROS. ADVISORS LP
FAQ
How long has BAKER BROS. ADVISORS LP held INSM?
BAKER BROS. ADVISORS LP has disclosed INSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BAKER BROS. ADVISORS LP's current position in INSM?
As of Q2 2026, BAKER BROS. ADVISORS LP holds 8.80M shares of INSM (INSMED INC), valued at $937.84M, representing 4.90% of its reported portfolio and ranking #7.
Has BAKER BROS. ADVISORS LP been buying or selling INSM?
In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP increased its position in INSM. The position peaked in Q1 2026 at 7.42M shares.
Which other funds hold INSM?
Other major institutional holders of INSM include Darwin Global Management, Ltd., Orbis Allan Gray Ltd, D. E. Shaw & Co, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.